Flexible ureteroscopic lithotripsy: First-line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient

被引:113
作者
Andreoni, C
Afane, J
Olweny, E
Clayman, RV
机构
[1] Washington Univ, Sch Med, Div Urol Surg, Dept Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
关键词
D O I
10.1089/089277901750299285
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Purpose: The surgical treatment of kidney and proximal ureteral stones in morbidly obese patients (> 14 kg/m(2)) remains difficult because shockwave lithotripsy is precluded by weight limitations and percutaneous nephrolithotomy is associated with difficult access and a high (9%) rate of transfusion. We review our experience with retrograde ureteroscopic lithotripsy in morbidly obese patients with renal and proximal ureteral stones. Patients and Methods: Between December 1992 and April 2000, five women and three men with a mean age of 46.5 years (range 33-68 years) and a mean body mass index of 54 (range 45-55.2) underwent 10 independent ureteroscopic procedures for urolithiasis. The average stone size was 11.1 mm (range 5-25 mm), Lithotripsy was performed with the holmium laser in eight patients (60%) the electrohydraulic lithotripter in four (30%), and the tunable-dye laser in the remaining patient. Stone-free status was defined as no stones visible on a plain film with nephrotomograms or CT scan at 3 months. Results: The mean operation time was 101 minutes (range 45-160 minutes), and 60% of the procedures were done on an outpatient basis, After the initial procedure, the stone-free rate was 70%, Two patients had fragments <4 mm, and no further therapy was undertaken. There was one complication: transient renal insufficiency (serum creatinine concentration 3.7 mg/dL) secondary to aminoglycoside toxicity. No transfusions were needed, Conclusion: In the morbidly obese patient with symptomatic stones <1.5 cm, ureteroscopic lithotripsy is safe, successful, and efficient.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 20 条
[1]   Essential arterial hypertension and stone disease [J].
Borghi, L ;
Meschi, T ;
Guerra, A ;
Briganti, A ;
Schianchi, T ;
Allegri, F ;
Novarini, A .
KIDNEY INTERNATIONAL, 1999, 55 (06) :2397-2406
[2]   PATHOPHYSIOLOGY OF OBESITY [J].
BRAY, GA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (02) :488-494
[3]   Body-mass index and mortality in a prospective cohort of US adults [J].
Calle, EE ;
Thun, MJ ;
Petrelli, JM ;
Rodriguez, C ;
Heath, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) :1097-1105
[4]   PERCUTANEOUS LITHOTRIPSY IN MORBID-OBESITY [J].
CARSON, CC ;
DANNEBERGER, JE ;
WEINERTH, JL .
JOURNAL OF UROLOGY, 1988, 139 (02) :243-245
[5]  
COCKCROFT DW, 1976, NEPHRON, V231, P524
[6]   Modification of the technique of percutaneous nephrolithotomy in the morbidly obese patient [J].
Curtis, R ;
Thorpe, AC ;
Marsh, R .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (01) :138-140
[7]   Ureteroscopic management of intrarenal calculi [J].
Fabrizio, MD ;
Behari, A ;
Bagley, DH .
JOURNAL OF UROLOGY, 1998, 159 (04) :1139-1143
[8]  
FLIER JS, 1998, WILLIAMS TXB ENDOCRI, P1063
[9]   Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor staghorn calculi [J].
Grasso, M ;
Conlin, M ;
Bagley, D .
JOURNAL OF UROLOGY, 1998, 160 (02) :346-351
[10]   ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH CUSHINGS-SYNDROME [J].
HATTON, J ;
PARR, MD ;
BLOUIN, RA .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (12) :974-977